Health aspects of cannabis: Revisited

International Journal of Neuropsychopharmacology

Volumn 1, Issue 1, 1998, Pages 71-80

  Hollister, Leo E ^a  

^a University of Texas Harris County Psychiatric Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000637586     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145798001060     Document Type: Review

References (99)

1. Abood ME, Martin BR (1992). Neurobiology of marijuana use. Trends in Pharmacological Science 13, 201-206.
2. Allebeck P, Adamson C, Engstrom R (1993). Cannabis and schizophrenia: A longitudinal study of cases treated in Stockholm County. Acta Psychiatrica Scandinavica 88, 21-24.
3. Andreasson S, Allebeck P, Endstrom A, Rudberg U (1987). Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet 2, 1483-1485.
4. Andreasson S, Allebeck P, Rydberg U (1989). Schizophrenia in users and nonusers of cannabis: A longitudinal study in Stockholm county. Acta Psychiatrica Scandinavica 79, 505-510.
5. Andreasson S, Allebeck P (1990). Cannabis and mortality among young men: A longitudinal study of Swedish conscripts. Scandinavian Journal of Social Medicine 8, 9-15.
6. Anthony JC, Heizer JE(1991) Syndromes of drug abuse and dependence. In: Rogins, LN, Regier CA. (Eds.) Psychiatric Disorders in America. New York: Free Press, Macmillan.
7. Barbers G, Gong H Jr., Tashki DP, Dishi J, Wallace JM (1987). Differential examination of bronchoalveolar lavage cells in tobacco cigarette and marijuana smokers. American Review of Respiratory Disease 135: 1271-1275.
8. Black S, Casswell S (1992). User reports of problems associated with alcohol and marijuana. British Journal of Addiction 87, 1275-1280.
9. Block RI, Ghoneim MM (1993). Effects of chronic marijuana use on human cognition. Psychopharmacology 20, 159-170.
10. Carrion JL (1990). Mental performance in long-term heavy cannabis use: A preliminary report. Psychological Reports 67, 947-952.
11. Chait LD, Pierri J (1992). Effects of smoked marijuana on human performance: A critical review. In: Murphy A, Bartke J (Eds.) Marijuana/Cannabinoids: Neurobiology and Neurophysiology. Boca Raton, FL: CRC Press.
12. Chaudry HR, Moss HB, Bashir A, Sulliman T (1991). Cannabis psychosis following bhang ingestion. British Journal of Addiction 86, 1075-1081.
13. Choi VS, Pish WR (1989). Cardiovascular effect of adolescent drug abuse. Journal of Adolescent Health Care 10, 332-337.
14. Cimbura G, Lucas DM, Bennett RC, Donelson AC (1990). Incidence and toxicological aspects of cannabis and ethanol detected in 1394 fatally injured drivers and pedestrians in Ontario. Journal of Forensic Science 34, 1035-1041.
15. Collins JA, Higginson JDS, McBoyle D, Webb SW (1985). Myocardial infarction during marijuana smoking in a young female. European Heart Journal 6, 637-638.
16. Comptom DR, Dewey WL, Martin BR (1990). Cannabis dependence and tolerance production. Advances in Alcohol and Substance Abuse 9, 129-147.
17. Deahl J (1991). Cannabis and memory loss (Editorial) British Journal of Addiction 86, 249-252.
18. Donald PF (1991). Marijuana and upper aerodigestive tract malignancy in young patients. In: Nahas GG, Latour G (Eds.) Pathophysiology of Illicit Drugs: Cannabis, Cocaine, Opiates. Oxford: Pergamon Press.
19. Eldridge JC, Landfield, PW (1990). Cannabinoid interactions with glucocorticoid receptors in rat hippocampus. Brain Research 534, 135-141.
20. Ferguson RP, Hasson J, Walker S (1989). Metastatic lung cancer in a young marijuana smoker. Journal of the American Medical Association 261, 41-42.
21. Fletcher JM Page, JB, Francis DJ, Copeland K, Naush J, Davis CM, Morris R, Korduskoph D, Satz P(1996) Cognitive correlates of long term cannabis use in Costa Rican men. Archives of General Psychiatry 53, 1051-1057.
22. Fried PA (1989). Postnatal consequences of maternal marijuana use in humans. Annals of the New York Academy of Science 562, 126-132.
23. Fried PA (1995). The Ottawa Prenatal Prospective Study (OPPS) methodological issues and findings. It's easy to throw out the baby with the bath water. Life Sciences 56, 2159-2168.
24. Ghodse AH (1986). Cannabis psychosis. British Journal of Addiction 81, 473-478.
25. Grufferman S, Scwartz AG, Ruymann FB, Maurer HN (1993). Parents' use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children. Cancer Causes Control 4, 217-214.
26. Hall W, Solowij N, Lemon J (1994). National Drug Strategy. The Health and Psychological Consequences of Cannabis Use. Monograph Series 25, pp. 210. Canberra: Australian Government Publishing Service.
27. Hendin H, Haas AP, Singer P, Eller M, Ulman R (1987). Living High: Daily Marijuana Use among Adults. New York: Human Sciences Press.
28. Hollister LE (1986). Health aspects of cannabis. Pharmacological Reviews 38, 2-20.
29. Hollister LE (1992). Marijuana and immunity. Journal of Psychoactive Drugs 24, 150-164.
30. Howlett AC, Bidaut-Russell M, Devane WA, Melvin LS, Johnson MR, Herkenham M (1990). The cannabinoid receptor, biochemical, anatomical and behavioral characterization. Trends in Neurosciences 13, 420-423.
31. Imade AG, Ebie JC (1991). A retrospective study of symptom patterns of cannabis-induced psychosis. Acta Psychiatrica Scandinavica 83, 134-136.
32. Johansson EK, Halldin MM, Agurell S, Hollister LE, Gillespie HK (1988a) Terminal elimination plasma half-life of delta-1-tetrahydrocannabinol (delta-1-THC) in heavy users of marijuana. European Journal of Clinical Pharmacology 37, 273-277.
33. Johansson E, Sjovall J, Noren K, Agurell A, Hollister LE, Halldin MM (1988b) Analysis of delta-1-tetrahydrocannabinol (THC) in human plasma and fat after smoking. Biochemical Chromatography 2, 101-104.
34. Johnson M, Melvin B, DeCosta BR, Rice KC, Herkenham M, Lynn AB, Little MD (1990). Cannabinoid receptor localization in brain. Proceedings of the National Academy of Science, USA 87, 1932-1936.
35. Kaslow RA, Blackwelder WC, Ostrow DG (1989). No evidence of a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-positive individuals. Journal of the American Medical Association 261, 3424-3429.
36. Kelly TH, Foltin RW, Emurian CS, Fischman MW (1990). Multidimensional behavioral effects of marijuana. Progress in Neuro-Psychopharmacology, Biology, and Psychiatry 14, 885-902.
37. Kopell BS, Roth WT, Tinklenberg JR (1978). Time course events of marijuana and ethanol on event-related potentials. Psychopharmacology 56, 15-20.
38. Leavitt J, Webb R, Norris G (1992). Performance of chronic marijuana users on neuropsychological tests. NIDA Research Monograph 84. Problems of Drug Dependence.
39. Leirer VO, Yesavage JA, Morrow DG (1989). Marijuana, aging and task difficulty effects on pilot performance. Aviation, Space and Environmental Medicine 61, 1145-1152.
40. Leirer VO, Yesavage JA, Morrow DG (1991). Marijuana carry-over effects on aircraft pilot performance. Aviation, Space and Environmental Medicine 62, 221-227.
41. Linzen DH, Dingemans PM, Lenior ME (1994) Cannabis abuse and the course of recent onset schizophrenia disorders. Archives of General Psychiatry 51, 273-279.
42. Lundquist T (1995). Chronic cannabis use and the sense of coherence. Life Sciences 56, 2145-2150.
43. Martinez-Arevalo MJ, Ordonez AC, Vare-Prieto Jr. (1994). Cannabis consumption as a prognostic factor in schizophrenia. British Journal of Psychiatry 164, 679-681.
44. Mathers DC, Ghodse AH, Caan AW, Scott SA (1991). Cannabis use in a large sample of acute psychiatric admissions. British Journal of Addiction 86, 779-784.
45. McBay AJ (1986). Drug concentrations and traffic safety. Alcohol, Drugs, and Driving 2, 51-59.
46. McGuire P, Jones P, Murray R (1993). Psychiatric symptoms in cannabis users. British Journal of Psychiatry 163, 698-701.
47. McGuire PK, Jones P, Harvey I (1994). Cannabis and acute psychoses. Schizophrenia Research 13, 161-168.
48. Miller NS, Gold MS (1989a). The diagnosis of marijuana (Cannabis) dependence. Journal of Substance Abuse Treatment 6, 183-192.
49. Miller NS, Gold M, Pottash AC (1989b). A 12-step treatment approach for marijuana (Cannabis) dependence. Journal of Substance Abuse Treatment 6, 241-250.
50. Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Keu K, Morrison RL, Vadolen KG (1990). Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Schizophrenia Bulletin 16, 31-56.
51. Musty RE, Kaback L (1995). Relationship between motivation and depression in chronic marijuana users. Life Sciences 56, 2151-2152.
52. Negrete JC, Knapp WC, Douglas DE, Smith WB (1986). Cannabis affects the severity of schizophrenic symptoms: Results of a clinical survey. Psychological Medicine 16, 515-520.
53. Negrete JC (1989). Cannabis and schizophrenia. (Editorial) British Journal of Addiction 84, 348-351.
54. O'Connell CM, Fried PA (1990). Prenatal exposure to cannabis: A preliminary report of postnatal consequences in school-age children. Neurotoxicology and Teratology 13, 63-69.
55. Ohlsson A, Widman M, Gillespie H, Hollister L, Agurell S, Halldin M, Lindgren JE (1986). Pharmacokinetics and metabolism of delta-1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacological Reviews 38, 21-43.
56. Ostrea EM Jr., Brady M, Cause S, Raymundo AL, Stevens M (1992). Drug screening of newborns by meconium analysis: A large-scale, prospective, epidemiologic study. Pediatrics 89, 107-113.
57. Page JW, Fletcher J, True WR (1988). Psychocultural perspectives on chronic cannabis use: The Costa Rica follow-up. Journal of Psychoactive Drugs 20, 57-62.
58. Patrick G, Geth AL (1985). Auditory and visual P300 event-related potentials are not altered in medically and psychiatrically normal chronic marijuana users. Life Sciences 56, 2135-2140.
59. Peck RC, Biasotti A., Boland PM, Mallory C, Reeve V (1986). The effects of marijuana and alcohol on actual driving performance. Alcohol, Drugs and Driving 2, 125-154.
60. Peralta V, Cuesta MJ (1992). Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatrica Scandinavica 85, 127-130.
61. Pertwee RG, Stevenson LA, Grodtin G, Gibson D, Mandelsoum A, Ettinger A, Mechoulam R, Devane WA, Hanus L., Breuer A. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
62. Polen MR, Sidney S, Tekawa IS, Sadler M, Freideman GD (1993). Health care use by frequent marijuana smokers who do not smoke tobacco. Western Journal of Medicine 158, 596-601.
63. Pope HG Jr., Vergelon-Todd D (1996). The residual cognitive effects of heavy marijuana use in college students. Journal of the American Medical Association 275, 521-527.
64. Podczech A, Frohner J, Steinbach K (1990). Acute myocardial infarcts in juvenile patients with coronary arteries. International Journal of Cardiology 30, 359-360.
65. Robbe HWJ, O'Hanlon JF (1993). Marijuana's effect on actual driving: Summary of a three-year experimental program. In: Utzelmann HD, Bergbaus G, Kroj G (Eds.) Alcohol, Drugs, and Traffic Safety. Volume 2. Cologne: Verlag TUV Rheinland.
66. Robison LL, Buckley JD, Daigle AE, Wells R, Benjamin D, Arthur CC (1989). Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. Cancer 56, 1904-1910.
67. Rodriquiz de Fonseca F, Carrera RA, Navvro M, Koob GF, Weiss F (1977). Activation of CRP in limbic during cannibis withdrawal. Science 276, 2050-2054.
68. Roffman RA, Stephens RS, Simpson EE, Whitaker DL (1988). Treatment of marijuana dependence: Preliminary results. Journal of Psychoactive Drugs 20, 129-137.
69. Rohr JM, Skowlund SW, Martin TC (1989). Withdrawal sequelae to cannabis use. International Journal of Addiction 24, 627-631.
70. Rolfe M, Tang CM, Sabally S, Todd JG, Sam EB, Habib n'JIR (1993). Psychosis and cannabis use in the Gambia: A case control study. British Journal of Psychiatry 163, 798-801.
71. Scallet AC (1991). Neurotoxicology of cannabis and THC: A review of chronic exposure studies in animals. Pharmacology, Biochemistry and Behavior 40, 671-676.
72. Shiona PH, Klebanoff MA, Nugent RP, Cotch MF, Wilkins DA, Rollins DE (1995). The impact of cocaine and marijuana use on low birth weight and pre-term birth: A multicenter study. American Journal of Obstetrics & Gynecology 172(1): 19-27.
73. Soderstrom CA, Triffilis AL, Shankar BS, Clark WE, Crowley RA (1988). Marijuana and alcohol use among 1023 trauma patients. Archives of Surgery 123, 733-737.
74. Solomons K, Neppe VM, Kuyl JM (1990). Toxic cannabis psychosis is a valid entity. South African Medical Journal 78, 476-481.
75. Solowij N, Michie P, Fox AM (1991). Effects of long-term cannabis use on selective attention: An event-related potential study. Pharmacology, Biochemistry and Behavior 40, 683-688.
76. Solowij N, Michie P, Fox AM (1995a). Differential impairments of selective attention due to frequency and duration of cannabis use. Biological Psychiatry 37, 731-739.
77. Solowij N (1995b). Do cognitive impairments recover following cessation of cannabis use? Life Sciences 56, 2119-2126.
78. Solowij N, Michie P, Fox AM (1997). Cognitive function in long-term cannabis users. In Nahas G, Burks T (Eds.) Drug Abuse in the Decade of the Brain. Amsterdam: IOS Press.
79. Spector S, Lancz G, Westrich G, Friedman H (1991). Delta-9-tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection. International Journal of Immunopharmacology 13, 411-417.
80. Stephens RS, Roffman RA (1993). Adult marijuana dependence. In: Baer JS, Marlatt GA, MacMahon RJ (Eds.) Addictive Behaviors across the Lifespan: Prevention, Treatment and Policy Issues. Newbury Park, CA: Sage Publications.
81. Struve FA, Straumanis JJ (1990). Electroencephalographic and evoked potentials methods in human marijuana research: Historical review and future trends. Drug Development Research 20, 369-388.
82. Struve FA, Straumanis JJ, Patrick G (1994). Persistent topographic quantitative EEG sequelae of chronic marijuana use: A replication study and initial discriminant function analysis. Clinical Electroencephalography 25, 63-74.
83. Taylor FM (1988). Marijuana as a potential respiratory tract carcinogen: A retrospective analysis of a community hospital population. Southern Medical Journal 81, 2113-2115.
84. Terhune KW (1992). The Incidence and Role of Drugs in Fatally Injured Drivers. Report No. DOT-HS-808-065. National Technical Information Service, Springfield, VA.
85. Thomas H (1993). Psychiatric symptoms in cannabis users. British Journal of Psychiatry 163, 141-149.
86. Thomas H (1996). A community survey of adverse effects of cannabis use. Drug and Alcohol Dependence 42, 201-207.
87. Thornicroft G (1990). Cannabis and psychosis. Is there epidemiological evidence for an association? British Journal of Psychiatry 157, 25-33.
88. Tunving K, Lundquist T, Eriksson GD (1995). 'A way out of the fog': An outpatient program for cannabis users. In: Chesher G, Consroe P, Musty R (Eds.) Marijuana: An International Research Report. Canberra, Australia: Australian Government Publishing Service.
89. Varma VK, Malhotra AK, Dang R, Das K, Nehra R (1988). Cannabis and cognitive functions: A prospective study. Drug and Alcohol Dependence 21, 147-152.
90. Volkow ND, Gillespie H, Mullani N, Tancriedi L, Grant C, Ivdnovic M, Hollister L (1991). Cerebellar metabolic activity by delta-9-tetrohydrocannabinol in human brain: A study with positron emission tomography and IGF-2-fluoro-2-deoxyglucose. Psychiatry Research: Neuroimaging 40, 69-78.
91. Warner R, Taylor D, Wright J, Sloat A, Springett HB, Arnold S, Weinberg H (1994). Substance use among the mentally ill: Prevalence, reasons for use and effects on illness. American Journal of Orthopsychiatry 64, 30-39.
92. Williams AG, Peat MA, Crouch DJ, Wells JK, Finkle BS (1986). Drugs in fatally injured young male drivers. Public Health Reports 100, 19-25.
93. Wise RA (1996). Addiction, drugs, and brain. Annual Review of Neuroscience 19, 319-340.
94. Woody GE, Cottler LB, Cacciola J (1993). Severity of dependence: data from the DSM-IV trials. Addiction 88, 1573-1579.
95. Wu TC, Tashkin, DP, Jiahed B, Rose JE (1988). Pulmonary hazards of smoking marijuana as compared with tobacco. New England Journal of Medicine 318, 347-351.
96. Yesavage JA, Leirer VO, Ditman J, Hollister LE (1985). 'Hangover' effects of marijuana/intoxication on aircraft pilot performance. American Journal of Psychiatry 142, 1325-1329.
97. Zimmerman S, Zimmerman AM (1990). Genetic effects of marijuana. International Journal of Addiction 91, 25, 19-33.
98. Zuardi AW, Morais SL, Guimares FS, Mechoulam R (1995). Antipsychotic effect of cannabidiol. Journal of Clinical Psychiatry 56, 485-486.
99. Zuckerman B, Frank DA, Hingson R, Amdro H, Levenson SM, Kayne H, Parker S, Vinci R (1989). Effects of maternal marijuana and cocaine use on fetal growth. New England Journal of Medicine 320, 762-768.